Articoli recenti
- Opocrin Group at CPHI Japan 2026
- Opocrin Group in New York City for DCAT 2026
- Thanks to Tafoxiparin, Opocrin reshapes the heparin paradigm and accelerates in favour of Women’s Health
- Opocrin S.p.A. awarded Top Employer 2026 certification
- Opocrin S.p.A. obtains FDA approval for the commercialization of Iron Sucrose and enters the U.S. market
Commenti recenti
No comments to show.

